The first new therapy for lupus, researched for 50 years, is on the list, and 7 are medicine advances for cancer treatments.
Read more information here.
What are the perspectives for this year? FDA will be at Terrapinn’s World Orphan Drug Congress USA 2012 analyzing the following topics:
– Importance of natural history studies in rare diseases
- The approach to improve pediatric regulatory impact
– Pediatric regulation for a global market
– Ethical aspects of clinical trial design
Understand the latest news about legislation, hear how governments in the US, Europe, Cana, Japan, Brazil and Taiwan are working together to harmonize regulations and incentive orphan and pediatric drug development.